seekingalpha.com
Senzime AB (publ) (SNZZF) Q4 2025 Earnings Call Transcript
Senzime AB (publ) (SNZZF) Q4 2025 Earnings Call Transcript
SNZZFSNZZFOTC
Loading
Latest News
Loading news...
accessnewswire.com
Senzime Launches TetraCom Connectivity Platform Enabling Universal Transmission of Anesthesia Data
UPPSALA, SE / ACCESS Newswire / February 19, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) today announced the launch of the TetraCom TM hospital connectivity platform. TetraCom is a first of its kind platform, enabling universal transmission of neuromuscular data directly into leading hospital enterprise systems such as Epic and Oracle Health (Cerner).
seekingalpha.com
Senzime AB (publ) (SNZZF) Q4 2025 Earnings Call Prepared Remarks Transcript
Senzime AB (publ) (SNZZF) Q4 2025 Earnings Call Prepared Remarks Transcript
accessnewswire.com
Senzime Secures Credit Line Facility of 50 MSEK
UPPSALA, SE / ACCESS Newswire / February 18, 2026 / Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) announces that the company has secured a credit line facility of 50 MSEK.
accessnewswire.com
Senzime Q4 2025: Accelerated Growth and Continued Clear Path to Profitability
UPPSALA, SE / ACCESS Newswire / February 18, 2026 / Senzime AB's (publ.) (STO:SEZI)(OTCQX:SNZZF) year-end report for January - December 2025 is now available on the company's website www.senzime.com.
accessnewswire.com
Invitation to Presentations of Senzime's Q4 and Year-End Report 2025
UPPSALA, SE / ACCESS Newswire / February 11, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter and year-end report for 2025 on February 18, 09:00 CET. The report will be published during the morning of the same day.
accessnewswire.com
Senzime Secures Major Ivy League US Hospital System Contract
UPPSALA, SE / ACCESS Newswire / January 21, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured another strategic contract in the US with a leading Ivy League university hospital system. The contract includes in its first phase an installation of 60 next-generation TetraGraph systems, and annual usage from these monitors are expected to exceed 10,000 disposable sensors at full implementation.
accessnewswire.com
Senzime's Next-Generation TetraGraph System Receives Regulatory Approval in Japan
UPPSALA, SE / ACCESS Newswire / December 17, 2025 / Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) today announced that its Next-generation TetraGraph® system has received regulatory clearance for sale in Japan from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
accessnewswire.com
Senzime Unveils the Next Set of Innovations in Neuromuscular Monitoring With the Launch of EMGINE Sirius
UPPSALA, SE / ACCESS Newswire / December 10, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation TetraGraph® system. The new EMGINETM Sirius software suite will be showcased at the 79th PostGraduate Assembly in Anesthesiology (PGA) conference, taking place December 12-15 in New York City, NY, USA.
accessnewswire.com
Senzime Secures Major TetraGraph Order from Leading UK NHS Hospital System
UPPSALA, SE / ACCESS Newswire / December 9, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) today announced that one of the leading NHS hospital trusts in the United Kingdom (UK) has ordered a total of 70 TetraGraph systems to standardize neuromuscular monitoring across all major operating rooms.
accessnewswire.com
Senzime to Present at Redeye and BioStock Investor Conferences
UPPSALA, SE / ACCESS Newswire / November 11, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), a leader in solutions for personalized anesthesia, today announced that Philip Siberg, CEO of Senzime, will be presenting at the following investor conferences this week. Redeye Medtech & Diagnostics Theme Event Date: Nov 12, 2025 Time: 11:45 CET Event Page: https://www.redeye.se/events/1110236/redeye-theme-medtech-diagnostics-4 Biostock Summit Date: Nov 13, 2025 Time: 14:40 CET Event Page: https://biostock.se/event/biostock-life-science-summit/ After the events, the presentations will be uploaded to Senzime's website at https://www.senzime.com/en/reports-presentations.
accessnewswire.com
Nomination Committee for Senzime Annual General Meeting 2026
UPPSALA, SWEDEN / ACCESS Newswire / November 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - A Nomination Committee consisting of shareholder representatives has been established for Senzime AB (publ.) in accordance with the principles adopted by the annual general meeting held on May 19, 2025.
seekingalpha.com
Senzime AB (publ) (SNZZF) Q3 2025 Earnings Call Prepared Remarks Transcript
Senzime AB (publ) (OTCQX:SNZZF) Q3 2025 Earnings Call October 29, 2025 6:00 AM EDT Company Participants Philip Siberg - Chief Executive Officer Presentation Philip Siberg Chief Executive Officer Okay. Good morning, good afternoon, depending on where you are.
accessnewswire.com
Senzime Q3 2025: Strong Growth and Clear Steps Towards Profitability
UPPSALA, SE / ACCESS Newswire / October 29, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - September 2025 is now available on the company's website www.senzime.com . Strategic events during and after the end of the third quarter Additional strategic hospital contracts secured in the U.S. market.
accessnewswire.com
Invitation to Presentations of Senzime's Third Quarter 2025 Report
UPPSALA, SE / ACCESS Newswire / October 23, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the third quarter report for 2025 on Oct 29, 09:00 CEST. The report will be published during the morning of the same day.
accessnewswire.com
Senzime Launches EMGINE, The Next-Generation Software Suite Advancing Neuromuscular Monitoring
UPPSALA, SE / ACCESS Newswire / October 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of EMGINETM, a proprietary software suite for its next-generation TetraGraph® platform. The new technology will be unveiled at the ANESTHESIOLOGY® 2025 conference, taking place October 11-13 in San Antonio, Texas, USA.
accessnewswire.com
Senzime Welcomes New European Pediatric Guidelines Recommending EMG-Based Neuromuscular Monitoring
UPPSALA, SE / ACCESS Newswire / October 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) welcomes today's presentation at the ESPA congress in Berlin of the first-ever pediatric guidelines for neuromuscular monitoring during anesthesia. The new guidelines recommend the use of electromyography (EMG)-based neuromuscular monitoring - the technology powering Senzime's TetraGraph system.
accessnewswire.com
Senzime Awarded Contract to Supply the U.S. Department of Defense and Walter Reed National Military Medical Center
UPPSALA, SE / ACCESS Newswire / September 17, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) today announces that the U.S. Department of Defense has awarded a contract to supply the TetraGraph® system to all major operating rooms at Walter Reed National Military Medical Center in Bethesda, Maryland. The installation furhter includes an expected annual purchase volume exceeding 5,000 TetraSens® sensors.
accessnewswire.com
Senzime Welcomes New Japanese Guidelines on Neuromuscular Monitoring
UPPSALA, SE / ACCESS Newswire / September 9, 2025 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) - today announced that the Japanese Society of Anesthesiology (JSA) has published updated clinical guidelines on neuromuscular monitoring. The 2025 revision builds on the guidelines last updated in 2019 and further strengthens the requirements for quantitative neuromuscular monitoring during anesthesia.